Maximizing PTH Anabolic Osteoporosis Therapy
Abstract
The subject of this research is the need for improved osteoporosis therapies. The purpose of this study is to test the efficacy of parathyroid hormone (PTH) mono-therapy and PTH+ antiresportive combination therapies on Nmp4-knockout (KO) and wild type (WT) mice. The scope of the research comprises the following specific aims: (i & ii) to determine the impact of Nmp4 on the efficacy of PTH mono- and combination therapies with bisphosphonates and the selective estrogen receptor modulator (SERM) raloxifene in ovariectomized (ovx) mice; (iii) to determine the cell type-specific contributions to the enhanced response of the Nmp4-KO mouse to these osteoporosis therapies.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2014
- Accession Number
- ADA610951
Entities
People
- Joseph Bidwell
Organizations
- Indiana University